ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Director, RWD Scientist at Eli Lilly and Company - ApplyBlast

Director, RWD Scientist

Eli Lilly and Company

1 month ago

4.0 on Glassdoor

Remote

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Director, RWD Scientist leads evidence generation strategy in Cardiometabolic Health, translating scientific ideas into tangible solutions using real-world data and analytics. This role involves driving the integration of Health Economics and Outcomes Research (HEOR) across the product lifecycle and leading the execution of complex studies. The position requires anticipating future field requirements and maximizing the value of AI and emerging technologies within the RWD workflow.

Responsibilities

Drive HEOR strategy integration from clinical development through commercialization
Design and execute real-world data studies to support evidence generation
Lead cross-functional teams to deliver high-impact scientific research

Skills

Qualifications

PhDMD

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.